Orchestra BioMed Holdings Inc. (OBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $560.38M
Last updated: Nov 17, 2026 at 4:15 PM ET
Orchestra BioMed Holdings Inc. (OBIO) Stock Chart
Orchestra BioMed Holdings (OBIO) has a latest price of $6.97 on Nov 17, 2026, 6.4% below its 52-week high of $7.45. Its price rose 76.9% over the past 12 months. The month-end price fell 40.1% over the 5 years through Oct 2026, a compound annual decline of 9.7%.
Price Chart
From Aug 2020 to Oct 2026, its highest month-end close was $19.57 in Mar 2023 and its lowest $2.48 in Sep 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OBIO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OBIO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 25.6%, and over 6 months it rose 74.3%. The month-end price rose 26.0% over the 3 years through Oct 2026, a compound annual rate of 8.0%.
| Period | Change |
|---|---|
| 1 month | +23.4% |
| 3 months | +25.6% |
| 6 months | +74.3% |
| 12 months | +76.9% |
| 12 months, with dividends | +76.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +26.0% | +8.0% |
| 5 years | -40.1% | -9.7% |
Price by Year
Its best calendar year was 2025, when the price rose 3.8%, and its weakest was 2024, when it fell 56.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $5.91 | +42.4% |
| 2025 | $4.15 | +3.8% |
| 2024 | $4.00 | -56.2% |
| 2023 | $9.13 | -8.5% |
| 2022 | $9.98 | -1.0% |
| 2021 | $10.08 | -21.3% |
Trading Range
The price is 17.4% above its 50-day average of $5.94 and 49.5% above its 200-day average of $4.66.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $6.97 | |
| 52-week high | $7.45 | -6.4% |
| 52-week low | $3.46 | +101.4% |
| 50-day average | $5.94 | +17.4% |
| 200-day average | $4.66 | +49.5% |
Price Risk
Over 3 years, its largest fall from a peak was 78.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.53 |
| Largest fall, 1 year | -34.8% |
| Largest fall, 3 years | -78.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OBIO
What is OBIO's 1-year price change?
Orchestra BioMed Holdings's price rose 76.9% over the past 12 months. With dividends included, the 12-month total return was 76.9%.
What is OBIO's 5-year price change?
Orchestra BioMed Holdings's month-end price fell 40.1% over the 5 years through Oct 2026, a compound annual decline of 9.7%. These figures leave out dividends.
What is OBIO's 52-week high and low?
Orchestra BioMed Holdings's 52-week high is $7.45 and its 52-week low is $3.46. Its latest price of $6.97 on Nov 17, 2026 is 6.4% below the high.
What is OBIO's beta?
Orchestra BioMed Holdings's 1-year beta against the S&P 500 is 1.53, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 34.8%.
Is the OBIO chart free?
Yes. Advanced Charting for OBIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OBIO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors